NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
41 hedge funds and large institutions have $4.97M invested in Nymox Pharmaceutical Corp in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
-4
Holders Change %
-8.89%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
15
Closed
12
Calls
$80K
Puts
$77K
Net Calls
+$3K
Net Calls Change
+$25K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.67M |
| 2 |
Goldman Sachs
New York
|
+$144K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$114K |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$72K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$55K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.17M |
| 2 |
State Street
Boston,
Massachusetts
|
-$663K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$181K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$177K |
| 5 |
Bank of New York Mellon
New York
|
-$147K |
